201 related articles for article (PubMed ID: 16247615)
1. Efficacy of micafungin for the treatment of candidemia.
Andes D; Safdar N
Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):662-4. PubMed ID: 16247615
[No Abstract] [Full Text] [Related]
2. International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.
Ostrosky-Zeichner L; Kontoyiannis D; Raffalli J; Mullane KM; Vazquez J; Anaissie EJ; Lipton J; Jacobs P; van Rensburg JH; Rex JH; Lau W; Facklam D; Buell DN
Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):654-61. PubMed ID: 16261306
[TBL] [Abstract][Full Text] [Related]
3. Caspofungin for refractory candidemia in neonates.
Manzar S; Kamat M; Pyati S
Pediatr Infect Dis J; 2006 Mar; 25(3):282-3. PubMed ID: 16511405
[No Abstract] [Full Text] [Related]
4. [A successful treatment with micafungin of candidemia due to Candida krusei].
Nonoyama M; Kume H; Kumagai K; Souma K; Sunakawa K
Kansenshogaku Zasshi; 2003 Nov; 77(11):982-5. PubMed ID: 14672012
[TBL] [Abstract][Full Text] [Related]
5. [Successful treatment with micafungin in a case of candidemia associated with pneumonia].
Hanada M; Imaoka H; Oshita Y; Rikimaru T; Aizawa H
Kansenshogaku Zasshi; 2005 Apr; 79(4):284-9. PubMed ID: 15977567
[TBL] [Abstract][Full Text] [Related]
6. Echinocandins for candidemia in adults without neutropenia.
Bennett JE
N Engl J Med; 2006 Sep; 355(11):1154-9. PubMed ID: 16971721
[No Abstract] [Full Text] [Related]
7. Caspofungin in combination with amphotericin B against Candida glabrata.
Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
[TBL] [Abstract][Full Text] [Related]
8. Successful caspofungin treatment of multidrug resistant Candida parapsilosis septicaemia in an extremely low birth weight neonate.
Yalaz M; Akisu M; Hilmioglu S; Calkavur S; Cakmak B; Kultursay N
Mycoses; 2006 May; 49(3):242-5. PubMed ID: 16681818
[TBL] [Abstract][Full Text] [Related]
9. Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation.
Girmenia C; Moleti ML; Micozzi A; Iori AP; Barberi W; Foà R; Martino P
J Clin Microbiol; 2005 Oct; 43(10):5395-6. PubMed ID: 16208029
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant.
Natale F; Castronovo A; Regoli D; De Curtis M; Manzoni P
Pediatr Infect Dis J; 2009 May; 28(5):452. PubMed ID: 19295457
[No Abstract] [Full Text] [Related]
11. Echinocandins in the management of invasive fungal infections, Part 2.
Morris MI; Villmann M
Am J Health Syst Pharm; 2006 Oct; 63(19):1813-20. PubMed ID: 16990627
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of micafungin in transplantation recipients.
Forrest GN; Rasetto F; Akpek G; Philosophe B
Transplantation; 2006 Dec; 82(11):1549. PubMed ID: 17164733
[No Abstract] [Full Text] [Related]
13. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
Pappas PG; Rotstein CM; Betts RF; Nucci M; Talwar D; De Waele JJ; Vazquez JA; Dupont BF; Horn DL; Ostrosky-Zeichner L; Reboli AC; Suh B; Digumarti R; Wu C; Kovanda LL; Arnold LJ; Buell DN
Clin Infect Dis; 2007 Oct; 45(7):883-93. PubMed ID: 17806055
[TBL] [Abstract][Full Text] [Related]
14. Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy.
Hakki M; Staab JF; Marr KA
Antimicrob Agents Chemother; 2006 Jul; 50(7):2522-4. PubMed ID: 16801435
[TBL] [Abstract][Full Text] [Related]
15. Septic Candida krusei thrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents.
Pan SC; Hsieh SM; Chang SC; Lee HT; Chen YC
Med Mycol; 2005 Dec; 43(8):731-4. PubMed ID: 16422304
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
[TBL] [Abstract][Full Text] [Related]
17. The echinocandin micafungin: a review of the pharmacology, spectrum of activity, clinical efficacy and safety.
Wiederhold NP; Lewis JS
Expert Opin Pharmacother; 2007 Jun; 8(8):1155-66. PubMed ID: 17516879
[TBL] [Abstract][Full Text] [Related]
18. Micafungin (Mycamine) for fungal infections.
Med Lett Drugs Ther; 2005 Jun; 47(1211):51-2. PubMed ID: 15961968
[TBL] [Abstract][Full Text] [Related]
19. [Micafungin in pediatric and adolescent patients].
Madero-López L
Rev Iberoam Micol; 2009 Mar; 26(1):62-4. PubMed ID: 19463279
[TBL] [Abstract][Full Text] [Related]
20. [Successful treatment of azole-refractory Candida guilliermondii fungemia with a combination therapy of micafungin and liposomal amphotericin B].
Saitoh T; Matsushima T; Shimizu H; Osaki Y; Yamane A; Irisawa H; Yokohama A; Uchiumi H; Handa H; Tsukamoto N; Karasawa M; Nojima Y; Murakami H
Rinsho Ketsueki; 2008 Feb; 49(2):94-8. PubMed ID: 18341039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
